Timothy P. Noyes, CHIEF EXECUTIVE OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 9,044 shares at $18.11 ($164K) on 2023-07-17, disclosed to the SEC on 2023-07-19.
Scheduled sale ($164k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.11 | 4,522 | $82K | 50.0% |
| 2 | $18.11 | 4,522 | $82K | 50.0% |
| Total | $18.11 avg | 9,044 | $164K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-18 | $494K | — | Filing → |
| AVTE | SELL | 2024-04-03 | $519K | — | Filing → |
| AVTE | SELL | 2023-11-03 | $11K | — | Filing → |